vimarsana.com
Home
Live Updates
Advanced Stage Mantle Cell - Breaking News
Pages:
Latest Breaking News On - Advanced stage mantle cell - Page 1 : vimarsana.com
JW Therapeutics Announces NMPA Acceptance of the Supplemental Biological License Application for Carteyva(R) in Patients with Relapsed or Refractory Mantle Cell Lymphoma
JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced that the National Medical Products Administration (NMPA) of China
Markj gilbert
Chinj hematol
China national medical products administration
Bristol myers squibb
National medical products administration
National significant new drug development program
Biological license application
Mantle cell lymphoma
Breakthrough therapy designation
Priority review
Chief medical officer
Overall survival
Advanced stage mantle cell
Clinical oncology
Refractory mantle cell lymphoma
Relmacabtagene autoleucel injection
JW Therapeutics Announces Receipt of Breakthrough Therapy Designation for Carteyva® in Mantle Cell Lymphoma in China
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Hong kong
Chinj hematol
A bristol myers squibb
National significant new drug development program
China national medical products administration
National medical products administration
Clearing limited hkex
Drug evaluation
Breakthrough therapy designation
Overall survival
Advanced stage mantle cell
Clinical oncology
Relmacabtagene autoleucel injection
Juno therapeutics
Bristol myers squibb
Hong kong exchanges
vimarsana © 2020. All Rights Reserved.